Cloud-HTMD
Financiado
A CLOUD APPLICATION PLATFORM FOR RATIONAL DRUG DISCOVERY USING HIGH THROUGHPUT M...
A CLOUD APPLICATION PLATFORM FOR RATIONAL DRUG DISCOVERY USING HIGH THROUGHPUT MOLECULAR DYNAMICS
Since 10 years, Acellera is at the forefront in the development of Molecular Dynamics (MD) applications for drug discovery, and is committed to developing next generation tools that facilitate adoption of this technology by a wide...
Since 10 years, Acellera is at the forefront in the development of Molecular Dynamics (MD) applications for drug discovery, and is committed to developing next generation tools that facilitate adoption of this technology by a wider segment of the drug discovery community.
Acellera’s strategy is to develop a powerful cloud-computing platform to widen access to high-throughput molecular dynamics simulations SaaS solution (Software as a Service). The aim is to accelerate market uptake of computational drug discovery and drive down the cost of development in the pharmaceutical industry. To this end a new software technology platform was released recently open source (HTMD.org) in order to help create a large community of scientists acquainted with our technology. HTMD aims to help dramatically accelerated pre-clinical research and to provide an order of magnitude increase in productivity compared to traditional in-vitro screenings.
In this project, Acellera proposes a new integrated computational chemistry solution for Cloud computing. The objectives that Acellera would like to achieve by recruiting an Innovation Associate are a) to develop a web-application to facilitate the use HTMD on cloud for biotech companies and smaller pharmaceutical companies, and b) to develop an innovative medicinal chemistry protocols via a web based and cloud-powered infrastructure.
The IA will be in charge of solving an industrial problem reported by the market. The development of the new tools will allow answering the unmet need to enable any small, medium company to perform similar in-silico protocols of top-pharmaceutical companies for accelerating their discovery pipelines.
ver más
Duración del proyecto: 18 meses
Fecha Inicio: 2017-02-27
Fecha Fin: 2018-08-31
Fecha Fin: 2018-08-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2018-08-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
INNOSUP-02-2016:
European SME innovation Associate - pilot
Cerrada
hace 8 años
Presupuesto
El presupuesto total del proyecto asciende a
75K€
Líder del proyecto
ACELLERA LABS
Investigacion, diseño, desarrollo, produccion, montaje y comercializacion de productos electronicos e informaticos de toda indole, tanto de...
Perfil tecnológico
TRL
4-5
89K
Perfil tecnológico
TRL
4-5
89K